SEK 263.4
Key Takeaways
Risk factor
Very vulnerable to price shocks
Profitability factor
Favourable analyst view
About
Bonesupport Holding AB (publ), an orthobiologics company, develops and commercializes injectable bioceramic bone graft substitutes for the treatment of bone voids in Europe, North America, and internationally. The company provides CERAMENT Bone Void Filler, an injectable, moldable, and drillable synthetic bone void filler that includes hydroxyapatite, calcium sulfate, and the radio-contrast agent iohexol; CERAMENT G,...
Company Valuation
Considering past and projected metrics, the stock is distinctly 'expensive' compared to its peers. In particular, the stock is overpriced on P/E, 'expensive' on EV/EBITDA
Target Price
The average target price of BONEX.ST is 432 and suggests 64% upside potential. Usually, this means a BUY recommendation among investment firms, or a recommendation to inc
